Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Ajanta Pharma Ltd.
NSE: AJANTPHARM
|
BSE: 532331
|
ISIN: INE031B01049
|
Industry: Pharmaceuticals
|
Mid-range Performer
2773.3000
75.60
(
2.80
%)
NSE
Jul 16, 2025
13:25 PM
Volume:
157.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Ajanta Pharma Ltd.
20 May 2020
2773.30
2.80%
Ajanta Pharma (BUY): Near-term growth concerns but demand outlook intact
Buy:
Ajanta Pharma Ltd.
by
BOB Capital Markets Ltd.
Target: 1650
BOB Capital Markets Ltd.
Ajanta Pharma (AJP) posted strong Q4 revenue/EBITDA growth of 32%/31% YoY to Rs 6.8bn/Rs 1.7bn.
Number of FII/FPI investors increased from 373 to 385 in Mar 2025 qtr.
More from Ajanta Pharma Ltd.
Recommended
Market trades flat, ICICI Lombard's Q1 net profit beats Forecaster estimates by 27%
Trendlyne Marketwatch |
16 Jul 2025, 01:06PM
Five stocks to buy from analysts this week - July 15, 2025
The Baseline |
15 Jul 2025, 06:44PM
Ajanta Pharma disputes ET article on FDA import alert
|
24 Jan 2017